rs771561899

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001134665.3(TRMT10A):​c.899G>A​(p.Gly300Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,614,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G300R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

TRMT10A
NM_001134665.3 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.296

Publications

0 publications found
Variant links:
Genes affected
TRMT10A (HGNC:28403): (tRNA methyltransferase 10A) This gene encodes a protein that belongs to the tRNA (Guanine-1)-methyltransferase family. A similar gene in yeast modifies several different tRNA species. Mutations in this gene are associated with microcephaly, short stature, and impaired glucose metabolism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014]
TRMT10A Gene-Disease associations (from GenCC):
  • microcephaly, short stature, and impaired glucose metabolism 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • primary microcephaly-mild intellectual disability-young-onset diabetes syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0202142).
BP6
Variant 4-99549209-C-T is Benign according to our data. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812. Variant chr4-99549209-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 1441812.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRMT10ANM_001134665.3 linkc.899G>A p.Gly300Asp missense_variant Exon 8 of 8 ENST00000394876.7 NP_001128137.1 Q8TBZ6V9HVY8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRMT10AENST00000394876.7 linkc.899G>A p.Gly300Asp missense_variant Exon 8 of 8 1 NM_001134665.3 ENSP00000378342.2 Q8TBZ6
TRMT10AENST00000273962.7 linkc.899G>A p.Gly300Asp missense_variant Exon 8 of 8 1 ENSP00000273962.3 Q8TBZ6
TRMT10AENST00000394877.7 linkc.899G>A p.Gly300Asp missense_variant Exon 8 of 8 2 ENSP00000378343.3 Q8TBZ6

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152186
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000796
AC:
20
AN:
251356
AF XY:
0.0000221
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000979
GnomAD4 exome
AF:
0.0000171
AC:
25
AN:
1461840
Hom.:
0
Cov.:
31
AF XY:
0.00000825
AC XY:
6
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33474
American (AMR)
AF:
0.000335
AC:
15
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000630
AC:
7
AN:
1111980
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152186
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41438
American (AMR)
AF:
0.000131
AC:
2
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.000140
AC:
17
EpiCase
AF:
0.0000546
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Oct 24, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 300 of the TRMT10A protein (p.Gly300Asp). This variant is present in population databases (rs771561899, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with TRMT10A-related conditions. ClinVar contains an entry for this variant (Variation ID: 1441812). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Benign:1
May 25, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.59
DANN
Benign
0.29
DEOGEN2
Benign
0.0035
T;T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0020
N
LIST_S2
Benign
0.34
.;.;T
M_CAP
Benign
0.0068
T
MetaRNN
Benign
0.020
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.0
N;N;N
PhyloP100
-0.30
PrimateAI
Benign
0.23
T
PROVEAN
Benign
0.73
N;N;N
REVEL
Benign
0.047
Sift
Benign
0.15
T;T;T
Sift4G
Benign
0.18
T;T;T
Polyphen
0.0
B;B;B
Vest4
0.041
MutPred
0.15
Gain of glycosylation at S302 (P = 0.0054);Gain of glycosylation at S302 (P = 0.0054);Gain of glycosylation at S302 (P = 0.0054);
MVP
0.040
MPC
0.19
ClinPred
0.017
T
GERP RS
-3.0
Varity_R
0.081
gMVP
0.066
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs771561899; hg19: chr4-100470366; API